GlobeNewswire

NOVA SCOTIA, CANADA, THE NEXT WAVE IN OCEAN TECHNOLOGY

Dela

Halifax, Nova Scotia, March 08, 2018 (GLOBE NEWSWIRE) -- Part of Canada's Ocean Supercluster, Nova Scotia is bringing 14 of its most innovative companies to London, UK, for Oceanology International 2018, March 13 to 15. Surrounded by the Atlantic Ocean, Nova Scotia is building on its international reputation in ocean observation, bringing world-class designers, manufacturers, experts and innovators to showcase their latest products and services in fields such as underwater acoustics and imaging, marine communication and navigation, robotics, and sensors.

"For Nova Scotia, this is an incredible opportunity to demonstrate the world-class work our companies are doing in ocean technology, and how it's driving our ocean economy" said Laurel Broten, President & CEO of Nova Scotia Business Inc., the province's business development agency. "Our province is home to companies who are leaders in their fields, which involves a multitude of ocean-related industries.  We also have the highest concentration of oceans-related Ph.Ds in Canada, and are leading the way in research and innovation."   

With the longest coastline in the world, Canada has a global advantage in the oceans industry and has recently committed up to $250 million of investment in the sector over the next five years. With an expected impact of thousands of jobs, and billions of dollars in GDP growth, Nova Scotia companies are uniquely positioned to be leaders in everything from ocean technology and observation, to marine-centric defence and security, to transportation and energy. 

At the centre of the ocean technology boom, Nova Scotia is building its industry infrastructure through the Centre for Ocean Ventures & Entrepreneurship (COVE), the region's collaborative space for ocean technology businesses, start-ups, researchers, and marine-based and service businesses. The space allows both local and global businesses to collaborate and take advantage of the province's 300 ocean-related companies, 60 high-tech innovators, and high concentration of oceans-related researchers.

Dynamic System Analysis Ltd.  (booth #E400) works with ocean engineers, naval architects, oceanographers - anybody with business in the water - to assess the motions and loads on vessels, structures, lines, and technologies in marine environments. "We're looking forward to meeting with companies across the ocean technology sector. We're especially interested in the companies being featured in the new Aquaculture stream presentation."

Enginuity Inc.  (booth #E400) offers a full spectrum of structural, metallurgical and electrical engineering, along with 'go-to-market' assistance. The company focuses on innovative, technical problem solving across a wide range of fields and applications.

GeoForce Group Limited  (booth #E401) has developed a digital high-resolution sub bottom profiler with negative polarity high volts output, eliminating the need to recover the towed body during survey operations. "We don't build anything we don't believe in."

GeoSpectrum Technologies Inc. (booth #E401) is making 2D and 3D particle motion more accessible to the industry with their line of M20 Particle Motion Sensors. Particle motion readings are made autonomous with a bottom-mounted system, which includes a frame, data logger, and battery pack.

Hawboldt Industries Ltd.  (booth #E400), designer and manufacturer of marine winches and deck hardware, provides custom-designed, innovative products to customers across the world. "We're looking to connect with new potential partners in the ocean science, oil and gas, and workboat industries.

InnovaSea Systems, Inc. (booth #E400) is a world leader in telemetry acoustic fish tracking and monitoring systems. "We'll be featuring our receivers with transponding capabilities, smaller tags with temperature and depth-sensors, and high-performance systems used for fish passage studies."

JASCO Applied Science  (booth #E400) is a world leader in the science of underwater sound, focusing on the potential effects on marine life. With offices in Canada, the United States, Europe, and Australia, JASCO provides a wide range of support. "We work with companies in all stages of environmental reviews and assessment of underwater sound for the renewable energy, oil and gas, marine construction, shipping, and defence sectors."

MetOcean Telematics  (booth #E400) is a world leader in integrated systems used for real-time environmental monitoring and an Iridium satellite product and service provider. "We are introducing and offering Iridium Certus Broadband, a product planned for commercial availability in mid-2018. Iridium NEXT is the next-generation satellite constellation, which replaces the existing network and provide broadband data speeds up to 1.4Mbps across 100% of the globe."

Ocean Sonics Ltd (booth #E400) is meeting with new and existing international distributors to showcase new products, including inline battery pack cages, smart recorders, and drifter buoys. The company is seeking new distribution and partnership opportunities. 

Pro-Oceanus Systems Inc.  (booth #E400) is releasing several new products with ocean technology applications and providing education and information on their new products. "Pro-Oceanus has been working with researchers for the past 20 years to solve their dissolved monitoring projects around the globe, from the ocean to groundwater to industrial systems."  

Turbulent Research  (booth #E400) designs and manufactures a wide range of subsea and onshore devices using acoustic and electromagnetic technologies for applications in pipeline monitoring, inspection, positioning and pipeline inspection gauge tracking.

Xeos Technology  Inc. (booth #E401) has been designing oceanographic beacons since 2004. "We've recently developed new tracking beacons for AUVs and UUVs, as well as beacons designed with special materials to prevent fouling in shallow warm waters. We're also developing a new line of oceanographic products that use GNSS for wave height and tide gauge measuring, and a new, low-cost, disposable surface current-tracker to be used in oil spill tracking."


Learn more about 
Nova Scotia's Ocean Technology sector  and the Nova Scotia companies participating at Oceanology London 2018, or visit the Canada Pavilion, March 13 - 15, in London, UK (Booths # E400-401).

Nova Scotia Ocean Technology Industry Facts

  • More than 300 companies are involved primarily in the oceans-sector in Nova Scotia, including more than 60 innovators of new, high-tech products and services.
  • Oceans account for 15% of Nova Scotia's GDP, and the ocean-technology industry accounts for about 1/3rd of total research and development among Nova Scotia businesses. 
  • The Canadian government has committed up to $250 million to ocean cluster development, driving millions into Nova Scotia's ocean economy. This investment will be matched dollar for dollar by the private sector.
  • As a result of the ocean supercluster, GDP impact is expected to be more than $14 billion over the next 10 years, positioning Canada as a global leader in the knowledge-based ocean economy.


Nova Scotia Business Inc. is the private-sector-led business development agency of Nova Scotia, Canada. We attract global investment to the province and work with our companies to be more successful exporters. Our clients benefit from our business advisory services, skill development and training, and support as they access global markets and succeed in the global economy.

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/ad68439f-9772-4edb-af52-d0e8b958d3f5

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/eaf0d1a0-52f2-43a7-8006-e907ce6a9b81

Laura MacDougall, Marketing Advisor
Nova Scotia Business Inc.
+1 (902)-424-0795
lmacdougall@nsbi.ca




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Nova Scotia Business Inc. via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum